Araştırma Makalesi
BibTex RIS Kaynak Göster

Yıl 2021, Cilt: 38 Sayı: 3s, 98 - 103, 09.05.2021

Gurkan Unsal Kaan Orhan

Öz

Kaynakça

  • References 1. Limones, A., et al., Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal, 2020. 25(3): p. e326-e336. 2. Morishita, K., et al., Treatment outcomes of adjunctive teriparatide therapy for medication-related osteonecrosis of the jaw (MRONJ): A multicenter retrospective analysis in Japan. J Orthop Sci, 2020. 3. Dunphy, L., et al., Medication-related osteonecrosis (MRONJ) of the mandible and maxilla. BMJ Case Rep, 2020. 13(1). 4. Kim, M.S., et al., Immediate reconstruction of mandibular defect after treatment of medication-related osteonecrosis of the jaw (MRONJ) with rhBMP-2/ACS and miniplate: Review of 3 cases. Int J Surg Case Rep, 2020. 66: p. 25-29. 5. Ruggiero, S.L., et al., American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg, 2014. 72(10): p. 1938-56. 6. Berg, B.I., et al., Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ). Dent J (Basel), 2016. 4(3). 7. Brierly, G.I., et al., Investigation of Sustained BMP Delivery in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ) in a Rat Model. Macromol Biosci, 2019. 19(11): p. e1900226. 8. Ristow, O., et al., Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ). J Craniomaxillofac Surg, 2015. 43(2): p. 290-3. 9. Wadia, R., Peri-implant MRONJ. Br Dent J, 2020. 228(6): p. 422. 10. Jasper, V., et al., Medication-related osteonecrosis of the jaw (MRONJ) stage III: Conservative and conservative surgical approaches versus an aggressive surgical intervention: A systematic review. J Craniomaxillofac Surg, 2020. 48(4): p. 435-443. 11. Steel, B.J., Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised? Community Dent Health, 2019. 36(4): p. 244-254. 12. Rao, N.J., et al., Effect of Periapical Diseases in Development of MRONJ in Immunocompromised Mouse Model. Biomed Res Int, 2019. 2019: p. 1271492. 13. Sarmiento, L.A., Resolution without surgery of an advanced stage of medication-related osteonecrosis of the jaw (MRONJ) in a patient who could not suspend her treatment for osteoporosis. Oral Oncol, 2019. 99: p. 104318. 14. Zirk, M., et al., Volumetric analysis of MRONJ lesions by semiautomatic segmentation of CBCT images. Oral Maxillofac Surg, 2019. 23(4): p. 465-472. 15. Shibahara, T., Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan. Jpn Dent Sci Rev, 2019. 55(1): p. 71-75. 16. Wazzan, T., et al., Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study. Spec Care Dentist, 2018. 38(6): p. 356-361. 17. Subramanian, G., et al., Identifying MRONJ-affected bone with digital fusion of functional imaging (FI) and cone-beam computed tomography (CBCT): case reports and hypothesis. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017. 123(3): p. e106-e116. 18. Stockmann, P., et al., Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig, 2010. 14(3): p. 311-7. 19. Unsal, G., et al., Medication-Related Osteonecrosis of the Jaw – A Case Report. ACTA SCIENTIFIC DENTAL SCIENCES, 2017. 1(5). 20. Goller-Bulut, D., G. Ozcan, and F. Avci, Changes in dimension of neurovascular canals in the mandible and maxilla: A radiographic finding in patients diagnosed with MRONJ. Med Oral Patol Oral Cir Bucal, 2018. 23(3): p. e282-e289. 21. Miyashita, H., et al., Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging. Dentomaxillofac Radiol, 2019. 48(8): p. 20190208. 22. Miyashita, H., et al., Clinical value of 3D SPECT/CT imaging for assessing jaw bone invasion in oral cancer patients. J Craniomaxillofac Surg, 2019. 47(7): p. 1139-1146. 23. Miyashita, H., et al., Clinical utility of three-dimensional SPECT/CT imaging as a guide for the resection of medication-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg, 2015. 44(9): p. 1106-9. 24. Fleisher, K.E., et al., Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw? J Oral Maxillofac Surg, 2016. 74(5): p. 945-58. 25. Koenig, L.J., Diagnostic Imaging Oral and Maxillofacial. Vol. 1. 2011: Amirsys, Inc. 26. White, S.C. and M.J. Pharoah, Oral Radiology : Principles and Interpretation. 7th ed. 2014: Elsevier Inc. 679.

WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?

Yıl 2021, Cilt: 38 Sayı: 3s, 98 - 103, 09.05.2021

Gurkan Unsal Kaan Orhan

Öz

Bisphosphonate-associated osteonecrosis of the jaws (MRONJ/BP-ONJ/ BRONJ) is a commonly seen disease. The main concern is to detect the exposed bone or even before occurring the exposed bone since it is not always painful, therefore a thorough clinical examination and radiological imaging are essential when MRONJ is suspected. In this review the imaging modalieties in regard to MRONJ: X-ray/Panoramic Radiograph, Cone Beam Computed Tomography (CBCT) and Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Imaging will be reviewed.

Anahtar Kelimeler

bisphosphonate ct

Kaynakça

  • References 1. Limones, A., et al., Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal, 2020. 25(3): p. e326-e336. 2. Morishita, K., et al., Treatment outcomes of adjunctive teriparatide therapy for medication-related osteonecrosis of the jaw (MRONJ): A multicenter retrospective analysis in Japan. J Orthop Sci, 2020. 3. Dunphy, L., et al., Medication-related osteonecrosis (MRONJ) of the mandible and maxilla. BMJ Case Rep, 2020. 13(1). 4. Kim, M.S., et al., Immediate reconstruction of mandibular defect after treatment of medication-related osteonecrosis of the jaw (MRONJ) with rhBMP-2/ACS and miniplate: Review of 3 cases. Int J Surg Case Rep, 2020. 66: p. 25-29. 5. Ruggiero, S.L., et al., American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg, 2014. 72(10): p. 1938-56. 6. Berg, B.I., et al., Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ). Dent J (Basel), 2016. 4(3). 7. Brierly, G.I., et al., Investigation of Sustained BMP Delivery in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ) in a Rat Model. Macromol Biosci, 2019. 19(11): p. e1900226. 8. Ristow, O., et al., Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ). J Craniomaxillofac Surg, 2015. 43(2): p. 290-3. 9. Wadia, R., Peri-implant MRONJ. Br Dent J, 2020. 228(6): p. 422. 10. Jasper, V., et al., Medication-related osteonecrosis of the jaw (MRONJ) stage III: Conservative and conservative surgical approaches versus an aggressive surgical intervention: A systematic review. J Craniomaxillofac Surg, 2020. 48(4): p. 435-443. 11. Steel, B.J., Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised? Community Dent Health, 2019. 36(4): p. 244-254. 12. Rao, N.J., et al., Effect of Periapical Diseases in Development of MRONJ in Immunocompromised Mouse Model. Biomed Res Int, 2019. 2019: p. 1271492. 13. Sarmiento, L.A., Resolution without surgery of an advanced stage of medication-related osteonecrosis of the jaw (MRONJ) in a patient who could not suspend her treatment for osteoporosis. Oral Oncol, 2019. 99: p. 104318. 14. Zirk, M., et al., Volumetric analysis of MRONJ lesions by semiautomatic segmentation of CBCT images. Oral Maxillofac Surg, 2019. 23(4): p. 465-472. 15. Shibahara, T., Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan. Jpn Dent Sci Rev, 2019. 55(1): p. 71-75. 16. Wazzan, T., et al., Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study. Spec Care Dentist, 2018. 38(6): p. 356-361. 17. Subramanian, G., et al., Identifying MRONJ-affected bone with digital fusion of functional imaging (FI) and cone-beam computed tomography (CBCT): case reports and hypothesis. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017. 123(3): p. e106-e116. 18. Stockmann, P., et al., Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig, 2010. 14(3): p. 311-7. 19. Unsal, G., et al., Medication-Related Osteonecrosis of the Jaw – A Case Report. ACTA SCIENTIFIC DENTAL SCIENCES, 2017. 1(5). 20. Goller-Bulut, D., G. Ozcan, and F. Avci, Changes in dimension of neurovascular canals in the mandible and maxilla: A radiographic finding in patients diagnosed with MRONJ. Med Oral Patol Oral Cir Bucal, 2018. 23(3): p. e282-e289. 21. Miyashita, H., et al., Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging. Dentomaxillofac Radiol, 2019. 48(8): p. 20190208. 22. Miyashita, H., et al., Clinical value of 3D SPECT/CT imaging for assessing jaw bone invasion in oral cancer patients. J Craniomaxillofac Surg, 2019. 47(7): p. 1139-1146. 23. Miyashita, H., et al., Clinical utility of three-dimensional SPECT/CT imaging as a guide for the resection of medication-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg, 2015. 44(9): p. 1106-9. 24. Fleisher, K.E., et al., Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw? J Oral Maxillofac Surg, 2016. 74(5): p. 945-58. 25. Koenig, L.J., Diagnostic Imaging Oral and Maxillofacial. Vol. 1. 2011: Amirsys, Inc. 26. White, S.C. and M.J. Pharoah, Oral Radiology : Principles and Interpretation. 7th ed. 2014: Elsevier Inc. 679.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Clinical Research
Yazarlar

Gurkan Unsal Bu kişi benim

Kaan Orhan

Yayımlanma Tarihi 9 Mayıs 2021
Gönderilme Tarihi 7 Mayıs 2020
Kabul Tarihi 17 Aralık 2020
Yayımlandığı Sayı Yıl 2021 Cilt: 38 Sayı: 3s

Kaynak Göster

APA Unsal, G., & Orhan, K. (2021). WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?. Journal of Experimental and Clinical Medicine, 38(3s), 98-103.
AMA Unsal G, Orhan K. WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?. J. Exp. Clin. Med. Mayıs 2021;38(3s):98-103.
Chicago Unsal, Gurkan, ve Kaan Orhan. “WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?”. Journal of Experimental and Clinical Medicine 38, sy. 3s (Mayıs 2021): 98-103.
EndNote Unsal G, Orhan K (01 Mayıs 2021) WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?. Journal of Experimental and Clinical Medicine 38 3s 98–103.
IEEE G. Unsal ve K. Orhan, “WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?”, J. Exp. Clin. Med., c. 38, sy. 3s, ss. 98–103, 2021.
ISNAD Unsal, Gurkan - Orhan, Kaan. “WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?”. Journal of Experimental and Clinical Medicine 38/3s (Mayıs 2021), 98-103.
JAMA Unsal G, Orhan K. WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?. J. Exp. Clin. Med. 2021;38:98–103.
MLA Unsal, Gurkan ve Kaan Orhan. “WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?”. Journal of Experimental and Clinical Medicine, c. 38, sy. 3s, 2021, ss. 98-103.
Vancouver Unsal G, Orhan K. WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?. J. Exp. Clin. Med. 2021;38(3s):98-103.
 Kapak Resmi İndir

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.